7 Nov 2012 | Medication Safety
The evaluation team, working with Sapere Research Group, has now completed initial site visits to Southern, Taranaki, Waitemata and Counties Manukau District Health Boards (DHBs). The discussions yielded a wealth of information on the implementation of the electronic medicine management (eMM) initiatives to date, which will be used by the Commission to inform future development and the roll-out of the national programme. The visits also provided valuable feedback and suggestions for the design of the evaluation, including the specific measures to be used and the approaches for collecting data.
A range of measurement and evaluation methodologies has been considered. Following advice and feedback from the Medication Safety Expert Advisory Group, and the four DHB sites, the evaluation will focus on measuring the burden of medication-related harm and on analysing the pattern of contributing factors/errors. The team will also develop and confirm the overarching framework for on-going measurement and evaluation.
Over the next six months, the evaluation team will undertake detailed data collection and analysis, and a second round of site visits. The quantitative and qualitative data they gather will be tested with a selection of key experts, in order to guide interpretation and assess clinical meaningfulness. The final evaluation report (including the confirmed framework for on-going measurement) will be completed by 30 June 2013.
A more in-depth update on progress in this key area will be in our electronic medication safety newsletter due for release in December 2012.